
Galmed Pharmaceuticals Ltd. (GLMD) Dividend History
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company focused on the development of innovative therapies for liver diseases. The company's lead product candidate, Aramchol, is a bile acid derivative developed for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Galmed also explores other therapeutic options targeting liver and metabolic conditions.
Website: https://www.galmedpharma.com
Dividend History
Galmed Pharmaceuticals Ltd. currently does not pay dividends